Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | N/A | $82,584 | $19,996 | $85,159 | $88,821 |
| Gross Profit | N/A | $54,157 | $13,824 | $58,606 | $61,350 |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | $14,714 | $4,458 | $35,153 | $14,066 |
Over the five-year period, the income statement data for Johnson & Johnson shows significant volatility in key financial metrics. Excluding 2020, where no data was reported, 2021 began with robust figures—revenue of USD 82.6 billion and a gross profit of USD 54.2 billion—paired with a net income of USD 14.7 billion. However, 2022 witnessed a steep decline of roughly 75% in both revenue and gross profit to USD 20.0 billion and USD 13.8 billion, respectively, with net income similarly dropping to about USD 4.5 billion. Such pronounced declines suggest that the company experienced major disruptions or one-off events that significantly impaired its top and bottom lines. Notably, operating income data remains unreported throughout, which limits insights into core business profitability and efficiency during this period. In 2023, the figures rebounded sharply, with revenue climbing to USD 85.2 billion and gross profit to USD 58.6 billion, and net income spiking to USD 35.2 billion, marking over a 300% recovery from the previous year. However, this recovery was not maintained in 2024, as revenue increased modestly to USD 88.8 billion but net income fell to USD 14.1 billion—a significant reversal. The cyclical swings, particularly the extreme contractions followed by rapid expansions, raise questions about the sustainability of these financial results. Overall, while the company shows potential for strong revenue generation, the volatile net income figures and missing operating income data suggest underlying operational or market challenges that warrant further examination to assess long-term financial health and stability.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.